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Abstract 
In the United States each year, there are an estimated 1.6 to 3.8 million sport-related 
traumatic brain injuries (TBI), which includes concussions. Due to increasing public awareness 
of concussion, there has been a significant amount of research and policy effort focused on 
reducing the overall number of concussion events. However, there has been less focus on the 
sequelae of concussion, including post-concussion syndrome (PCS). PCS can involve a variety 
of physical, cognitive, and psychiatric symptoms, and these symptoms persist for months or even 
years in some patients recovering from concussion. However, PCS has traditionally been 
diagnosed and treated as a single clinical entity. Many of the studies identified in the included 
systematic review used PCS diagnosis as the principal outcome, rather than tracking individual 
symptoms. Only one study examined potential interactions between PCS symptoms, finding that 
the presence of sleep disturbance was associated with concomitant depressive symptoms. Here, 
we propose a prospective cohort study that will involve using previously-validated survey 
instruments to track sleep disturbance and affective symptoms in particular, and quality of life 
and post-concussion symptoms more generally, to identify and describe relationships between 
predictor-outcome pairs that show potential for statistical significance, as well as determining 
direction of causality. The patients included in this study will be recruited from a University-
based Post-Concussion Clinic. Each subject will undergo specialized measurements such as 
posturography and neurocognitive assessment, which may also be examined as potential 
predictors. The predictor-outcome relationships will be described using either summary 
measures (for pairs with dichotomous inputs) or an as-yet-undetermined regression model (for 
pairs with continuous inputs). This study comprises a first step towards the creation of targeted 
treatments for PCS, a strategy that would lower the public health burden of concussion.  
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Introduction 
“I couldn’t see,” said Richard Sherman, a cornerback for the Seattle Seahawks, in a 2013 
column for Sports Illustrated [1]. Sherman was describing what he reported was the only 
concussion he had suffered while playing in the National Football League (NFL). He went on to 
say that he stayed in that game despite his symptoms, and that this decision “paid off” when he 
caught his first professional career interception two quarters later.  
Sherman’s sentiment on “playing through” pain, including concussions, mirrors that of 
generations of athletes before him. In recent decades, however, this tradition has been countered 
by growing concerns about the acute and chronic effects that concussions have upon athletes, 
particularly at the youth and college sports levels. Two of the potential consequences that have 
received significant coverage are Chronic Traumatic Encephalopathy (CTE) and Second Impact 
Syndrome (SIS). CTE is most commonly seen in professional athletes, and is definitively 
diagnosed via autopsy. It presents similarly to Alzheimer’s disease (e.g. impaired mood, 
behavior, cognition, motors skills) and develops as a result of repeated head blows during a 
professional athletic career [2]. SIS is defined as the “catastrophic consequence of repeated head 
injury in sport,” typically thought to be due to cerebral swelling [3]. It is thought to pose the 
greatest risk to athletes who suffer repeated concussions within the space of a single athletic 
game or match without giving the brain sufficient time to heal. After a 13 year-old named 
Zackery Lystedt suffered debilitating injury thought to be due to SIS in a 2006 junior varsity 
football game, Washington state passed a law in 2009 mandating automatic removal of athletes 
from competition if a concussion is suspected [4]. Due to increased public awareness of SIS and 
other concussion sequelae, all fifty U.S. states had passed similar laws by 2013.  
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As of 2006, there were an estimated 1.6 to 3.8 million sport-related traumatic brain 
injuries (TBIs) each year in the United States [5]. Up to 65% of those injuries occur among 
children aged five to eighteen years [6]. Many of these head injuries are classified as mild TBIs 
(mTBI), a term which is often used as a synonym of concussion (both terms will be used 
interchangeably in this paper). A common sequela of these millions of concussions suffered each 
year is Post-Concussion Syndrome (PCS). As defined in the International Statistical 
Classification of Diseases and Related Health Problems 10th Revision (ICD-10), the symptoms 
of this condition include headache, dizziness, fatigue, irritability, insomnia, noise sensitivity, and 
loss of concentration and/or memory [7]. In order to make the diagnosis, though, the complex of 
symptoms in a given patient need not involve any specific combination of these. Estimates vary 
depending on sampling procedures, diagnostic criteria, methodology, and time intervals used, but 
in general studies have found that around 10% of patients with recent mTBI suffer prolonged 
recovery or go on to develop persistent PCS [8 – 10].  
The economic burden of TBI (including all severity levels) among patients who are 
treated and released in emergency departments (ED) has most recently been estimated at $17.8 
billion (2010 dollars) annually in the United States, which includes costs of medical treatment as 
well as productivity loss [11]. Among children, the development of PCS is associated with 
increased risk of chronic conditions including anxiety, depression, and migraine headaches [12]. 
The daytime confluence of fatigue, emotional symptoms, and mental fogginess in PCS has been 
shown to negatively affect work and/or school performance for up to a month after concussion in 
the average patient [13]. Prolonged PCS can also place a significant burden on patients’ family 
members and disrupt familial dynamics, as parents focus on caring for their affected child, to the 
detriment of their other children [14, 15].  
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PCS appears to involve a combination of physiological and psychological etiologies. 
Several characteristic manifestations of PCS have been well-established in the peer-
reviewed literature, but the natural history and underlying pathophysiology of PCS remains 
unclear. Some hypothesize that the etiology is largely physiological. Supporting evidence 
includes studies in animal models, which have shown that concussion can lead to disrupted 
neuronal cell membranes, poorly-regulated ionic flux, and altered cerebral glucose metabolism 
[16]. Available clinical evidence in support of this hypothesis includes a 2013 study of 19 
patients who demonstrated global brain atrophy on magnetic resonance imaging (MRI) a year 
after suffering a mTBI when compared to 22 matched healthy controls [17]. Analogous studies 
using other imaging methods have also documented extensive abnormalities on positron 
emission tomography (PET) and functional MRI (fMRI) in patients with a history of mTBI, 
further indicating the possibility of a structural or physiological etiology of PCS [18, 19]. 
However, many of the imaging findings described in these and related studies were non-specific. 
Similar findings might also be seen in patients with conditions such as migraines, depression, or 
neurodegenerative diseases. In addition, the severity of the documented imaging abnormalities 
was not consistently correlated with symptom severity in these studies. 
The contrary (some would say complementary) hypothesis is that PCS has a strong 
psychological component. This hypothesis appears reasonable on its face; many of the cognitive, 
mood, and sleep symptoms associated with PCS can also manifest as part of certain somatoform 
or affective disorders. A 2008 study on American soldiers returning from Iraq, in which a history 
of mTBI did not significantly affect soldiers’ health after controlling for co-morbid diagnoses of 
post-traumatic stress disorder (PTSD) and depression, demonstrated the potential for overlap 
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between PCS and psychiatric conditions [20]. However, this study retrospectively surveyed 
soldiers concerning “losing consciousness (knocked out),” “being dazed, confused, or ‘seeing 
stars,’” or “not remembering the injury,” and so the results may have been vulnerable to recall 
bias and/or confounded by acute stress responses that subjects experienced at the time of injury.  
There is some evidence that psychiatric comorbidities are more common in patients who 
develop PCS relative to the general population [21]. Studies in pediatric patients with recent 
mTBI have shown that patients may report subjective PCS symptoms even after their cognitive 
test results have normalized, and that children with pre-morbid behavioral maladjustment are at 
greater risk of developing PCS [22, 23]. However, few studies have specifically investigated 
potential interactions between mTBI and psychiatric comorbidities in the development of other 
PCS symptoms, such as headaches or sleep disturbance.  
 
The study of PCS is made difficult by conflicting diagnostic criteria. 
In some ways, research on PCS is made more difficult by the amorphous nature of the 
PCS symptom complex itself. While there are a number of well-established symptoms and 
clinical findings associated with PCS, there is no “classic” presentation of the syndrome as a 
whole. As a result, the clinical diagnosis of PCS is vulnerable to inconsistent application between 
different providers, or even between different patients of the same provider. The lack of 
agreement between the definitions of PCS provided by ICD-10 versus that of the Diagnostic and 
Statistical Manual of Mental Disorders, 5th Edition (DSM-5) make PCS difficult to diagnose and 
treat, and thereby presents an obstacle to carrying out robust prospective studies. As an example 
of this definitional conflict, the ICD-10 definition notes that PCS can include functional 
impairments such as concentration or memory deficiencies, while the DSM-5 definition (referred 
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to as “Major or Mild Neurocognitive Disorder due to Traumatic Brain Injury” in the DSM, a 
revision from earlier editions’ “postconcussion disorder” terminology) requires evidence of 
affective symptoms or personality changes [7, 22, 24].  
In determining the incidence of PCS among patients who have suffered mTBI, the 
nebulous nature of the syndrome in conjunction with these conflicting definitions can produce 
contradictory diagnostic results. As illustration of this, PCS incidence in the pediatric population 
has been estimated at anywhere from 21 to 59%, even if only the ICD-10 definition is used [25]. 
A 2005 study found that providers’ diagnostic evaluations for PCS tended to produce markedly 
conflicting results depending on the clinical criteria used (e.g. ICD-10 versus the then-current 
DSM-IV-TR), even when both sets of criteria were applied to the same slate of patients [26]. 
Further, some characteristic symptoms of PCS are also prevalent – or at least prevalently self-
reported – among populations without head injury [27]. These diagnostic discrepancies have 
therapeutic implications as well. While the DSM’s criterion that symptoms be present three 
months following the date of the mTBI may lend that definition greater specificity, the ability to 
diagnose PCS at earlier intervals via ICD-10 criteria (i.e. within four weeks of injury) allows for 
earlier and potentially more effective interventions for a given patient.  
Given the potential ramifications in the professional and personal lives of patients 
recovering from concussion, in conjunction with the definitional difficulties inherent to PCS 
diagnosis, it is important to gain a better understanding of PCS’ etiology and natural history. 
Which patients are at greatest risk of developing prolonged PCS? Can patients be “categorized” 
on the basis of risk factors (e.g. male versus female, sport-related versus motor vehicle collision, 
history of sleep or psychiatric conditions)? Might such categorizations enable early, targeted 
  
Palm 9 
treatment? In addition to PCS as a whole, there are specific manifestations that especially 
warrant increased study, such as psychiatric and sleep-related manifestations.  
In order to design a study capable of answering some of these questions, a literature 
review was conducted to assess the status of peer-reviewed literature on this topic, as well as to 
identify pertinent clinical findings to track. This paper will compare observational studies of 
incident PCS among patients recovering from recent concussion (i.e. within the prior few months 
or year). These studies were examined with a focus on comparing outcomes and measures 
related to sleep disturbance (e.g. quality, quantity, timing, consistency) and affective symptoms 
(e.g. personal and family historical factors, incident symptoms during recovery), as well as 
interactions between these two potential manifestations of PCS.  
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Systematic Review 
Literature Search and Article Screening Methods 
Inclusion and exclusion criteria 
No registered review protocol was created or followed in producing this systematic 
review. The inclusion and exclusion criteria that were used in screening studies are detailed in 
Appendix #1. Briefly, the search focused on observational studies of patients with recent 
concussion (typically within twelve months of the concussion). While review articles were not 
included, the review articles’ citation lists were hand searched to screen for additional 
publications potentially relevant to this review. The citation lists of included articles were also 
hand-searched. Clinical trials were not included for the purposes of this review because their 
research designs seek to eliminate inter-variable relationships inherent to the natural history of 
PCS; these relationships are our primary interest in planning our new study. Because clinical 
trials were not included, ClinicalTrials.gov was not consulted as an additional reference source.  
Studies that focused on measurement of serum biomarkers in the setting of concussion 
were excluded. Studies of military or veteran populations were also excluded because the 
specific injury mechanisms (e.g. blast injuries) and psychosocial stressors experienced by 
military populations may make these studies’ findings less generalizable to the population from 
which our new study will draw (e.g. primarily referrals of adolescents and young adults for 
sports-related concussions). This review specifically included articles that examined risk factors 
for, or consequences of, sleep and mood symptoms in the setting of concussion recovery. These 
particular aspects of PCS have not been well-characterized in the literature, and they might lend 
themselves to early, targeted interventions. Since the acute diagnosis and treatment of concussion 
has gradually evolved and become increasingly standardized since the early 2000s, particularly 
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in sports, studies more than ten years old as of June 2016 were excluded. Finally, because our 
new study will specifically focus on the causes, components, and outcomes of prolonged PCS, 
only studies with greater than one month of follow-up measurements were included. 
 
Literature search strategy and article screening 
The PubMed MEDLINE and Cochrane Library databases were used to conduct the 
literature search. No article authors were contacted. The literature searches were frozen on June 
14, 2016 for final synthesis of results. The full search strategy used with the MEDLINE and 
Cochrane Library databases is described in Appendix #2. Essentially, there were three groups of 
search terms that related to our proposed research focus: (1) population of interest (i.e. 
“adolescents,” “adults,” “humans”), (2) exposure of interest (i.e. “concussion,” “brain injury”), 
and (3) risk factors/outcomes of interest (i.e. “depression,” “anxiety,” “sleep,” “factors,” and 
variations thereof). Neither quotation marks nor MeSH term restrictions were used when 
searching; searches were allowed to automatically map to variations of each search term. The 
article screening process was performed by one reviewer (RP) as summarized in Appendix #3. 
To start with, the reviewer discarded duplicate articles from the database searches and applied 
the criteria shown in Appendix #1 to screen articles based on the information presented in their 
titles and abstracts. The reviewer retained items that appeared applicable on initial screening, and 
then performed a full-text screen of the remaining articles, again applying the criteria shown in 
Appendix #1. 
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Data extraction and quality assessment 
Data extraction was performed by the same reviewer. The reviewer used a piloted form 
that corresponded to the column headings seen in Appendix #4: Authors (Year), Sample, Study 
Design, Measurements, Key Findings, Strengths, and Limitations. The “Key Findings” presented 
in Appendix #4 were narrowed to include only the factors/outcomes of interest (namely, sleep- 
and mood disorder-related findings), and the “Measurements” column only included those 
measurements that had a direct bearing upon each article’s key findings. Due to resource 
constraints, article authors were not contacted regarding methodology or results that were 
unclear or unstated in the published articles. The reviewer assessed each of the remaining studies 
for risk of bias, using the approach and risk of bias item bank described by Viswanathan and 
colleagues [28]. This process included assessments of potential confounding, selection bias, 
detection bias, and attrition bias for each study.  
In the course of the data extraction process, the methods of the included articles were 
summarized with an eye toward best practices for future research in this field of study. The 
summarization of results represents an attempt at distilling what is known about sleep 
disturbance and affective symptom manifestations of PCS thus far. This review of the articles’ 
results is qualitative. The studies reviewed used a wide variety of survey instruments, scoring 
methodologies, and outcome reporting formats. Due to this lack of homogeneity, I2 was not 
computed to determine the consistency of the studies summarized here, nor were any meta-
analyses, sub-group analyses, or meta-regressions performed on the extracted data. Finally, the 
overall risk of bias of the accumulated literature was assessed.  
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Results 
Study selection 
The inclusion of post-concussion syndrome (without quotes) as a search criterion 
restricted the number of search results by a factor of about fifty in both the MEDLINE and 
Cochrane Library databases. However, we submit that the inclusion of this criterion was 
justified, as the term “post-concussion syndrome” has been present in the medical lexicon for 
decades. Experiments with removing this criterion generated ample noise with negligible 
additional signal in the search results. Hand searches of articles’ citation lists were implemented 
in part to compensate for the risk that the search strategy may have been overly-narrow. 
As shown in the PRISMA flow diagram in Appendix #3, there were 234 total results 
from the MEDLINE and Cochrane databases. Hand search of review articles and the included 
articles’ citation lists yielded 17 additional articles. After excluding eight duplicates, 243 items 
remained. After screening titles and abstracts based on the criteria described in Appendix #1, 159 
of these articles were excluded. Following a full-text screen of the remaining 84 articles, 69 of 
them were excluded. Of these 69 articles, eleven focused on military and veteran populations, 
eight were review articles (which were subsequently hand-searched for relevant citations), 
twenty-seven did not specifically examine the risks/outcomes of interest, and twenty-four did not 
include greater than one month of follow-up measurements. This left fifteen studies meeting all 
inclusion criteria.  
 
Study characteristics 
 All fifteen studies included in this review were published in peer-reviewed journals in 
August 2006 or later. Twelve were prospective cohort studies [27, 29 – 39]
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included a control group [27, 35 – 38]. These control groups were composed of healthy controls 
[27, 37], patients with non-head injuries [35, 36], and patients with orthopedic injuries [37, 38]. 
Two of these studies’ control subjects were matched on age and sex [37, 38]; the other 
prospective cohort studies that included controls used either convenience or consecutive 
sampling. There were two retrospective cohort studies, both of which were conducted via chart 
review [40, 41]. Neither of these two studies included controls. Finally, there was one case-
control study that included two controls for each case, matched on age and sex [42].  
Four of the studies only included pediatric patients  [30, 31, 38, 41], two of which 
comprised separate analyses of data from the same cohort [30, 31]. Of note, two studies used 
pre-existing concussion registries to conduct chart reviews [40, 42]; the remaining thirteen 
studies recruited subjects (including controls, where applicable) upon their presentation to an 
emergency department (ED). Study lengths varied widely: the shortest one was six weeks [40], 
eleven studies were three months long [27, 29 – 32, 35 – 37, 39, 41, 42], one was six months 
long [33], one was 24 months long [38], and one was three years long [34]. The most common 
survey instrument used was the Rivermead Post-Concussion Questionnaire (RPQ) [43], which 
was used as a general inventory to track post-concussion symptoms in eight of the studies [27, 30 
– 33, 35, 36, 39, 40]. Beyond the RPQ, however, the survey instruments used varied widely 
among the articles that were reviewed; no other instrument was used in more than two of the 
studies. 
 
Summary of key findings 
 Sleep disturbance is one of the symptoms classically associated with PCS, and the studies 
reviewed here indicated that it is one of the most common symptoms reported by patients with 
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recent mTBI [31, 33, 35]. More specifically, mTBI patients appear to have increased sleep onset 
latency [35]. However, the evidence overall paints a mixed picture regarding sleep disturbance in 
the setting of mTBI recovery. Two studies found greater sleep disturbance in mTBI patients 
compared to healthy and/or non-head injured controls [37, 38], with a stronger effect size noted 
in older patients [37]. However, another study with comparable sample size detected a similar 
prevalence of sleep disturbance (about 21%) both among subjects with mTBI at three months 
post-injury as well as controls [27]. A separate study indicated that female sex, psychosocial 
problems, and frequent pain acted as confounding factors in determining the incidence of sleep 
disturbance among mTBI patients (at least in pediatric populations) [38]. 
 Other evidence sought to characterize the underlying mechanism of PCS-related sleep 
disturbance. Short sleep duration (e.g. less than 7 hours) and/or self-reported perception of poor 
sleep was associated with daytime dysfunction [35], poor self-care [38], and greater overall 
severity of self-reported PCS symptoms [41]. One study found that self-reported reasons for poor 
sleep evolved over the time course of concussion recovery (e.g. due to “pain from injury” at ten 
days post-injury, versus “frequent awakenings” at three months post-injury) [40]. Unique among 
PCS symptoms, self-reported sleep disturbance tended to worsen over time; 21.6% of one 
study’s subjects developed sleep disturbance after initial treatment and discharge from the ED, 
suggesting delayed onset of this symptom at three to four weeks post-injury [31]. Another study 
found that the prevalence of sleep disturbance among mTBI patients increased from 13.3% at ten 
days post-injury to 33.5% at six weeks [40]. In the latter study, Chaput and colleagues also found 
that subjects who reported sleep disturbance at ten days and six weeks post-injury were also 9.9 
and 6.3 times more likely, respectively, to report concomitant feelings of depression [40]. 
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Finally, for some patients, post-mTBI sleep disturbance symptoms may continue for years – 
much longer than the typical length of prospective cohort studies in this area of research [34].  
  Among the studies that measured it, depressed mood was a relatively uncommon PCS 
symptom, but it was a statistically significant predictor of PCS morbidity. Multiple studies found 
that patients with pre-mTBI depression (either documented in the patient’s chart or self-reported 
upon presentation to ED following mTBI) were significantly more likely to suffer from 
persistent PCS at three months post-injury and required more time to recover before returning to 
full activity [29, 30, 33, 42]. Morgan and colleagues also found that a positive family history of 
mood disorders or other psychiatric diagnoses predicted persistent PCS at three months post-
injury [42]. Only one study with relatively small sample size (n = 14) found that baseline 
depression did not correlate with PCS persistence at 3 months post-injury [32]. However, 
depressed mood was less prevalent among mTBI patients compared to other PCS-related 
symptoms in these same studies, and it tended to resolve relatively quickly [31]. 
 Some studies also examined the incidence of PTSD and non-specific anxiety symptoms 
in patients with recent mTBI. Similar to depressed mood, self-reported anxiety at the acute stage 
of mTBI recovery predicted persistent PCS at three months post-injury [29, 33]. PTSD appears 
to be more prevalent among mTBI patients versus non-head injured or healthy controls [37]. 
However, another study that specifically examined interactions between mTBI and PTSD 
diagnoses found that mTBI was predictive of PTSD diagnosis, but not PCS, at three months 
post-injury [36]. 
 Some of the reviewed studies evaluated potential predictors of prolonged post-concussion 
symptom duration. A history of multiple concussions was associated with longer average 
duration of post-concussion symptoms (about 24 days versus 12 days) [30]. Patients who 
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expressed belief that post-concussion symptoms would persist chronically tended to have longer 
duration of symptoms as assessed by the RPQ [39]. Finally, patients who eventually developed 
PCS were more likely to experience delayed onset of post-concussion symptoms (i.e. onset of 
symptoms at least three weeks post-injury that were not present at the acute stage following 
mTBI) [42]. However, Lagarde and colleagues found that PCS diagnosis at three months post-
injury (a main outcome used in many of the studies reviewed here) was an imprecise benchmark 
to use, as the prevalence of PCS among mTBI patients ranged from 21.2% to 53.4% at three 
months post-injury time point, depending on the PCS definition that was used (i.e. RPQ, ICD-10, 
DSM-IV, or Laborey) [36]. 
 
Risk of bias across studies 
 Strengths and limitations (including potential sources of bias) for individual studies are 
documented in Appendix #4. The only study with methodology that was concerning was that of 
Kostyun and colleagues [41]. Their study did not use universal time points, but instead used one-
way analysis of variance (ANOVA) to compare each subject’s first, second, and third Immediate 
Post-Concussion Assessment and Cognitive Testing (ImPACT) results, regardless of timing. The 
first, second, and third iterations of ImPACT testing for a given patient were (on average) 
completed 22 ± 18 days, 44 ± 41 days, and 76 ± 74 days post-injury, respectively. More 
generally, all twelve of the prospective cohort studies reviewed here recruited subjects upon 
presentation to an ED following a mTBI [27, 29 – 39]. Seven of the twelve prospective trials did 
not include control groups [29 – 34, 39]. 
 As is common in long-term prospective studies such as those included in this review, 
several authors had difficulty recruiting a high proportion of eligible patients to avoid sampling 
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bias, and several suffered large or differential loss to follow-up [29, 30, 35, 36]. Therefore, these 
studies were vulnerable to confounding via various demographic, socioeconomic, and 
psychosocial factors. However, inclusion and exclusion criteria were largely sensible and 
consistent across all studies, except that most studies did not exclude patients taking narcotics or 
similar medications that affect the brain. 
 
Discussion 
This systematic review yielded several insights about the predictors, effects, and 
interactions between sleep disturbance and affective symptoms in the setting of PCS. There was 
evidence that sleep disturbance was one of the most common features of PCS [33, 35], that the 
disturbance tended to worsen over the time course of concussion recovery [31, 40], and that for 
some patients the symptoms took months or even years to resolve [34]. While depressed mood 
appeared to be a less-common manifestation of PCS overall, it was a significant predictor of PCS 
morbidity months after a head injury [29, 33, 42], and it tended to appear in conjunction with 
sleep disturbance [40], at least in a sample of pediatric mTBI patients.  
These findings came with some caveats, however. While the statistical analyses appeared 
to be robust in many cases, the methods used in the article by Kostyun and colleagues were 
concerning. Subjects’ sequences of ImPACT test results were compared without regard to the 
time interval since injury for a given test result; for instance, the third ImPACT testing for one 
subject might conceivably have been completed before (in terms of days since injury) the first or 
second testing session for another subject. This non-universal timing of assessments likely 
violates the assumption that responses for each group are independent and identically distributed 
normal random variables, meaning that it was inappropriate for the authors to use one-way 
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ANOVA in their analysis. A better approach might have been to use generalized linear mixed 
model regression [44]. 
Some of the other studies had methodological concerns. Several articles noted that they 
conducted follow-up surveys via telephone interviews, but did not note whether these 
interviewers were masked, rendering the studies vulnerable to interviewer bias [34, 35, 39]. 
While not always necessary in cohort studies, the lack of a control group in the prospective 
studies reviewed here does present an issue, due to their outcomes being measured via self-
reported responses to subjective questions on symptom inventories [29, 30, 33, 34]. This meant 
that authors could not adjust for intra-subject variance over time, whether due to changing life 
circumstances or simply how subjects approach the questions. 
The sampling methods used in many of these studies – namely, recruitment from the ED 
– also presents a methodological problem. A recent descriptive study in a large pediatrics-
focused health system found that nearly 82% of patients within their system who suffered a 
concussion presented first to a primary care provider, not an emergency room [45]. Although this 
particular study focused on a pediatric population and has not been replicated, it nonetheless 
raises concerns about the external validity of recruiting from the ED for studies of mTBI.  
 
Potential limitations  
 It is also important to consider the limitations of this review, including the search strategy 
and the inclusion and exclusion criteria that were used. Although MEDLINE and the Cochrane 
Library together include a significant portion of the peer-reviewed medical literature, the 
literature search might have yielded additional articles if additional databases had been included, 
such as SPORTDiscus or CINAHL. Therefore, there is potential for publication bias that may 
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influence the validity of this review’s synthesis of evidence. Further, the literature search, article 
screening, and data extraction procedures were completed by only one reviewer (RP), increasing 
the risk of errors in article screening or data extraction. As this systematic review was meant to 
assist the design of a new, longitudinal study based at an outpatient concussion clinic, the 
inclusion and exclusion criteria were meant to include only articles that focused on populations, 
exposures, measurements, and outcomes that would be most applicable and useful in designing 
this new study. 
 
Implications for future research and clinical care 
A striking aspect of our literature search results was the relatively young age of the 
articles that were initially identified: about 76% were published within the past decade. Of the 
fifteen articles we eventually included, nine of them had been published within the past five 
years. All this is to say that concussion recovery is a relatively young, growing field of research 
whose methodological practices continue to evolve. 
In particular, methods for measurement of concussion and its effects on the brain and 
body continue to be a vexing issue. Concussion is a clinical diagnosis; it is often not visible on 
conventional imaging modalities, and as of yet there is no blood test that can detect it. While 
there exist objective (albeit costly and relatively invasive) methods for measuring sleep, 
researchers must rely on patient self-report for most potential manifestations of post-concussion 
syndrome such as nausea, headache, forgetfulness, fatigue, and depression. Post-concussion 
symptom inventories such as the RPQ (used by eight of the studies reviewed here) do not 
autonomously detect these symptoms, but simply ask the patient whether they have noticed them 
[43]. These questions about symptoms are inherently subjective and may be influenced by social 
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stigma or similar factors (such as when asking pediatric patients about depression [31]), making 
it difficult to reliably identify trends in PCS manifestations across a population.  
However, based on current evidence, the inherent subjectivity of many post-concussion 
survey tools such as the RPQ may have a hidden advantage when determining PCS prognosis for 
a given patient. This advantage lies in the fact that they are measuring patients’ perceived 
symptoms. One of the most unexpected and compelling themes to arise from this systematic 
review was the apparent influence of patients’ perceptions upon the course and duration of their 
post-concussion symptoms. In one of the studies reviewed, patients who expected the duration of 
their post-concussion symptoms to be similar to that of a chronic disease (rather than, say, a viral 
illness) were significantly more likely to be diagnosed with PCS at three months post-injury [39]. 
Separately, perception of poor sleep was associated with greater self-reported PCS symptom 
severity [41]. In multiple studies, sleep disturbance was one of the few PCS symptoms to exhibit 
delayed-onset and increased prevalence among mTBI patients in the post-acute period [31, 40].  
This phenomenon of evolving PCS symptomatology raises the question of physiological 
versus psychological contributions to PCS etiology. Future research should further investigate 
the natural history of sleep disturbance in the setting of PCS. Acute post-mTBI predictors of 
increased burden or resiliency in regards to post-concussion sleep disturbance should be 
identified. In particular, the interactions between sleep disturbance and affective symptoms in the 
setting of PCS should be further elucidated; only one of the included studies examined this 
potential interaction [40] . 
From a clinical perspective, the results of this systematic review underscore the 
importance of concussion education at the initial post-injury evaluation. These findings do not 
change the current standard of care, which involves a prescription for physical and cognitive rest 
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initially, and then gradually increasing activity as tolerated. However, this review’s findings 
regarding the significance of self-perception of symptoms as a predictor for PCS underscore the 
importance of discussing the typical duration of post-concussion symptoms with the patient and 
their family at the acute visit. Providers should provide reassurance but follow-up closely if 
symptoms last longer than expected. Finally, health care providers should specifically counsel 
mTBI patients about the importance of sleep in concussion recovery, as well as basic techniques 
for achieving a better night’s rest (i.e. sleep hygiene). 
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Proposed Research Design 
General Information and Summary 
Purpose: 
To contribute to improved scientific understanding of the etiology and natural history of post-
concussion syndrome (PCS), and to describe clinical measurements, historical risk factors, or 
other potential predictors associated with shortened duration of symptoms following concussion 
(or alternatively, factors associated with prolonged duration of post-concussion symptoms). 
Participants: 
Subjects will be drawn from among patients referred to a weekly post-concussion clinic (PCC) 
located in a sports medicine and training facility on the campus of a large research university. 
Procedures (methods): 
1. Standardize the clinical measurements conducted in PCC, such as history-taking 
(including past medical history, PMH; mechanism of injury; and severity of injury), 
physical exam, Buffalo Concussion Treadmill Test (BCTT), Sensory Organization Test 
(SOT), CNS Vital Signs (CNSVS), and self-report survey tools (administered via the 
Research Electronic Data Capture (REDCap) platform hosted at UNC-Chapel Hill.  
2. Use these standardized measurement data in aggregate to identify clinical findings and 
treatment modalities that are associated with shorter duration of PCS symptoms. 
3. Implement these standardized measures prospectively to collect data on symptomatology 
and typical time required before a given patient can return to full activity (RTA).  
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Initial Considerations and Study Rationale 
 Sleep disturbance and affective symptoms have long been established as common clinical 
manifestations of Post-Concussion Syndrome (PCS). As evidenced by the articles reviewed 
above, the mechanisms of potential interactions between sleep disturbance and affective 
symptoms, as well as the direction of causality between PCS and these comorbidities, have not 
been well-characterized. There is also limited data on the usefulness of objective post-concussion 
measurements, such as posturography and neurocognitive assessment, in predicting PCS 
prognosis for a given patient. As such, we propose to use our pre-existing outpatient post-
concussion clinic (PCC) as a base for a longitudinal study of these potential predictors and 
comorbidity interactions using detailed medical histories, standardized interviews to evaluate for 
post-concussion symptoms (including symptoms that are ongoing as well as acute-stage 
symptoms that may have regressed), objective post-concussion measurements at initial 
evaluation, and extended follow-up of PCS symptoms using previously-validated surveys.  
 Although the paradigm is gradually evolving, sleep disturbance and affective symptoms 
have traditionally been treated as components of the PCS symptom complex using standard 
protocols such as physical and cognitive rest, rather than as treatable conditions in and of 
themselves. Ideally, symptom-targeted treatments would allow providers to prescribe pre-
emptive (based on risk factors and symptoms at the acute stage) and abortive (in cases where 
new, unpredicted symptoms develop) therapies to shorten the time course of concussion recovery 
and mitigate the economic and public health burdens of PCS. Devising effective interventions, 
though, will require improved understanding of PCS’ etiology and natural history, as well as the 
interplay between its array of potential manifestations. With our new study, we seek to contribute 
to this improved understanding. 
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The articles included in the above systematic review tracked sleep disturbance and 
affective symptoms using exclusively self-report measurements. This reliance upon self-report 
measures does present an issue in populations of patients recovering from TBI, as a number of 
short-duration studies have found significant discrepancies in detection of sleep disturbance via 
self-report measures (e.g. Pittsburgh Sleep Quality Index, PSQI; Diagnostic Interview for 
Insomnia, DII; Epworth Sleepiness Scale, ESS) compared to objective measures used in the 
same slates of patients (e.g. polysomnography, PSG; Multiple Sleep Latency Test, MSLT) [46, 
47, 48]. However, beyond their higher costs and relative invasiveness, many of the objective 
measures used in these studies were cross-sectional and/or vulnerable to measurement bias, as 
they typically involved only one to three measurements per subject and were generally not 
measured at universal time points (relative to date of injury) across all subjects.  
Self-report measures may yield a less reliable quantitative picture of sleep disturbance in 
mTBI patients, but they still have some advantages compared to most objective modalities of 
sleep measurement. Self-report measures can capture night-to-night or week-to-week sleep 
variability as well as subjects’ self-perception of their sleep quality, the latter of which may be a 
significant predictor of PCS prognosis [39]. In the future, our research group may explore the use 
of cost-efficient objective sleep measures for use at home (such as fitness trackers) for potential 
inclusion in a longitudinal study. This study, however, will use self-report instruments to conduct 
follow-up measurements of subjects’ sleep disturbance and affective symptoms.  
The uniqueness of this research proposal stems from its concurrent measurement of 
subjects’ sleep, affective symptoms, function (i.e. time required for RTA), and other 
manifestations of PCS, all tracked in a longitudinal fashion. In addition, subjects will be drawn 
from an outpatient PCC that receives referrals from variety of providers (including emergency 
  
Palm 26 
departments and outpatient primary care physicians) and from a broad geographic area across the 
Eastern and Piedmont portions of North Carolina. This research design will allow enhanced 
study of interactions and causal relationships among long-established symptoms and risk factors 
associated with PCS, while avoiding common issues of external validity (due to recruitment 
directly from ED) and discrepant application of diagnostic criteria (due to involvement of many 
different providers) that have been faced by other studies in this area of research. 
 
Study Aims and Hypotheses 
 Aim #1(a). Describe the relationship between pre-morbid sleep problems and post-concussion 
sleep disturbance. 
Previous studies have consistently demonstrated an association between PCS and sleep 
disturbance [49]. Given that sleep disturbance has been shown to sometimes worsen in the month 
immediately following an mTBI [31, 40], we hypothesize that self-reported pre-morbid sleep 
problems is associated with greater post-concussion sleep disturbance. 
  
Aim #1(b). Describe the relationship between pre-morbid personal and/or family history of 
psychiatric conditions or migraines and post-concussion sleep impairment. 
Prior studies have demonstrated that personal and/or family history of migraines or 
psychiatric conditions (e.g. affective disorders) are associated with increased risk of prolonged 
PCS [29, 30, 33, 42]. There is mixed evidence on whether a past medical history of migraines is 
similarly predictive (both studies focused on pediatric patients) [30, 42]. However, to our 
knowledge no study has shown whether such historical findings are associated with increased 
likelihood of post-concussion sleep disturbance. Given this result in conjunction with how 
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commonly sleep disturbance occurs among post-concussion patients [31, 33, 35, 49], we 
hypothesize that pre-morbid personal and/or family history of migraines or psychiatric diagnoses 
is associated with greater PCS-related sleep disturbance, with no differential effect based upon 
subject age. 
  
Aim #1(c). Describe the effect of at least one previous concussion upon the degree of sleep 
impairment and affective symptoms in patients recovering from mTBI. 
It has been established that the effects of recurrent concussions appear to be additive in 
some respects, with multiple concussions leading to increased severity of cognitive impairment, 
longer duration of post-concussion symptoms, and greater risk of additional concussions in the 
future [8, 30, 50]. However, there is limited data in regard to an additive effect of recurrent 
concussion in producing specific PCS symptoms. We hypothesize that among patients 
recovering from recent mTBI, a history of one or more previous concussions is associated with 
greater sleep disturbance and affective symptoms during recovery. 
  
Aim #2. Describe the relationship between the development of delayed-onset, self-reported, post-
concussion sleep disturbance post-concussion affective symptoms. 
PCS is often associated with, and can have similar symptomatology as, certain 
psychiatric conditions such as depression or anxiety disorders [51]. There is evidence that the 
development of PCS may have a psychological component, including findings that patient 
perceptions can influence the duration of PCS symptoms that they experience [39]. There is also 
evidence from studies of pediatric populations that the aggregate burden of PCS-related sleep 
disturbance tends to increase over the first three to four weeks following concussion. We would 
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like to investigate whether these findings are connected. The initial symptoms experienced by a 
patient may result more from a physiological response to the mTBI, before evolving to a 
combination of symptoms driven more by psychological factors. While this may not hold true for 
more complex cases such as patients with a history of multiple recent concussions, we 
hypothesize that subjects with delayed onset of self-reported sleep disturbance (i.e. onset at one-
month post-injury or later) is associated with increased likelihood of concomitant affective 
symptoms.  
  
3. Describe the relationship between the degree of sleep disturbance and/or affective symptoms 
and the severity of overall PCS symptoms.  
Although the underlying mechanisms are not completely understood, sleep is generally 
thought to benefit neuronal healing as well as overall brain health [52]. One recent study has 
shown that patients recovering from mTBI who slept more than usual tended to demonstrate 
greater cognitive deficits on testing; the authors speculated that the increased sleep was needed 
for healing [41]. As noted above, Chaput and colleagues found that post-concussion sleep 
disturbance was associated with concomitant depressed mood [40]. Multiple studies have found 
that pre-injury depression is associated with increased likelihood of PCS at three months post-
injury [29, 30, 33, 42].  
To our knowledge, none have found that new depression symptoms in the acute stage 
following concussion is associated with prolonged PCS, although it seems reasonable to expect 
that anhedonia or similar affective symptoms may lead to decreased motivation or increased 
apprehension about returning to activity. We hypothesize that sleep disturbance is positively 
correlated with overall duration of PCS symptoms. While we expect that overall PCS symptom 
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severity is positively correlated with the presence of pre-injury affective disorder diagnoses, we 
do not hypothesize a significant correlation with acute-stage affective symptoms following 
mTBI. 
  
4. Describe the relationship between pre-injury chronotype and the degree of post-concussion 
sleep disturbance and affective symptoms, as well as its relationship with overall severity of PCS 
symptoms. 
Previous meta-analyses have shown that “morningness” is associated with decreased 
cognitive ability but increased academic achievement, while “eveningness” is associated with 
increased cognitive ability but decreased academic achievement [53]. Having an eveningness 
chronotype also appears to be associated with a greater prevalence of depressive symptoms [54]. 
However, to our knowledge, the interaction between chronotype, sleep disturbance, and affective 
symptoms has not been previously evaluated in the setting of PCS. Most previous research on 
chronotypes has been conducted with sift workers, which may not be generalizable to mTBI 
patients who have been prescribed physical and cognitive rest. Therefore, we hypothesize that 
chronotype will not affect the likelihood of sleep disturbance or affective symptoms following 
concussion. However, since patients recovering from concussion typically require increased 
sleep, and since circadian rhythms associated with eveningness chronotype are often 
asynchronous with typical school and work schedules, we hypothesize that eveningness 
chronotype is associated with increased overall severity of PCS symptoms.  
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Methods 
Participants 
The Post-Concussion Clinic (PCC) has been held on a weekly basis for several years 
now. The patients seen in this clinic tend to be referred due to persistent, refractory post-
concussion symptoms, and they may present anywhere from a few weeks to a few years 
following their concussion(s). It is a unique clinical setting, particularly compared to most 
primary care offices. A one-hour time slot is allotted for each patient, enough to take a detailed 
history and collect ample data in-office. Given the PCC’s location within a sports medicine 
research center and training facility on the campus of a large research university, we are also able 
to perform specialized clinical measurements. These measures, all of which will be detailed in 
sections to follow, include posturography, computerized neurocognitive assessments, exercise 
testing, and functional activity testing. 
Of the fifteen articles included in our systematic review, only one directly compared 
pediatric patients (18 years of age or younger) with young adults (19 to 30 years of age) [37]. 
Therefore, as part of our longitudinal study, we will recruit patients aged 12 and older in order to 
investigate age as a factor that may affect the natural history of PCS. We will rely on subjects' 
verbal confirmations that they are at least the age of majority (which is 18 years old in North 
Carolina), or alternatively on subjects' parent or guardians' verbal confirmation if the child is 
younger than the age of majority. Concussion status will be confirmed via medical records 
and/or communication with the referring provider (e.g. primary care provider or athletic trainer). 
We will not use any further means of determining each subject's group status. 
The majority of the data collected in this study will be derived from history, physical 
exam, and self-report. Patients will be counseled that they need not disclose sensitive 
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information (e.g. personal and/or family psychiatric history) if they feel that they would risk 
psychological trauma by doing so. If a patient has sustained a recent concussion without 
resolution of most of their concussion-related symptoms (i.e. the patient cannot be described as 
mildly symptomatic or asymptomatic at time of presentation), then that patient will not be tested 
in order to avoid physical or mental harm that might result from loss of balance or cognitive 
exertion. In these cases, the timeline for follow-up testing will be jointly determined by the 
patient (or their guardian), the providers at the PCC, and the referring provider. We contend that 
these measures present no greater than minimal risk, as defined in the FDA Code of Federal 
Regulations (CFR) § 50.3 [55].  
Some of the other measures that will be used, including posturography, neurocognitive 
assessments, and exercise testing, may impart a minor increase over minimal risk to the subject. 
However, these tests are often clinically indicated for patients that present to the PCC based upon 
standards of care. In addition, these measurements, when considered in aggregate over the 
study’s entire sample, will contribute to general knowledge about the natural history and clinical 
course of PCS. The study subjects, or their guardians if applicable, will always be given the 
option to halt participation in the study or to decline to complete certain tests. Therefore, we feel 
that the study includes adequate protection measures for children as a vulnerable population, in 
accordance with the FDA CFR § 50.53 [56]. 
Subjects in the proposed study will be recruited through the PCC. Our strategy will be to 
offer informed consent to participate in this study to all patients seen in PCC who meet the 
criteria for enrollment. Subjects over the age of majority (18 in North Carolina) will give consent 
as adults, whereas for subjects who are minors (i.e. less than 18 years old) their parents or 
guardians will give consent by proxy if they wish for their child to participate. The study will be 
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fully explained to all potential subjects before consent is requested. Following counseling about 
the study, potential subjects will be allowed to review the informed consent paperwork in a 
private room, individually or in conjunction with their parent or guardian if they are younger 
than 18 years old. They will have a chance to discuss any questions or concerns they have about 
the study with the investigators after reviewing the informed consent paperwork. 
Patients presenting to PCC who do not (or whose parents/guardians do not) wish to 
participate will undergo normal history and physical, post-concussion testing (if clinically 
indicated), and treatment. No clinical data generated from this latter group's PCC visits will be 
included in data analysis; they will still follow-up with in PCC as needed but unlike study 
participants they will not be sent the batches of follow-up surveys in the months following their 
appointment.  
As of now, the PCC does not see many patients with acute concussion (i.e. less than 21 
days since injury). PCC patients are referred from all over the state by a variety of providers and 
at a wide range of time points in the course of their recovery from concussion. Therefore, a 
potential difficulty with carrying out this study is the potential variance of time intervals since 
mTBI event among subjects. In the worst case, the variance of this time interval may interfere 
with our ability to administer initial testing as well as collect follow-up self-report instruments at 
universal time points across all study subjects. 
 
Study Design 
With this study, we are seeking to better understand the natural history of sleep 
disturbance and affective symptoms in the setting of PCS, investigate possible interactions 
between these PCS symptoms, and potentially establish direction of causality without testing any 
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specific interventions other than standard of care. As such, we designed this as a prospective 
cohort study. We next considered duration of follow-up. Although most uncomplicated 
concussions resolve within a few weeks (i.e. less than about 21 days), ten of the fifteen studies 
from our systematic review included three months of follow-up (relative to each subject’s date of 
head injury). As reported by Spinos and colleagues, between 40% and 80% of mTBI patients 
report PCS-like symptoms within weeks of suffering mTBI, while about 50% of patients report 
experiencing these symptoms for up to three months afterward [9]. However, only 10% to 15% 
of mTBI patients continue to report PCS-like symptoms more than a year after injury. While 
many of the studies we reviewed included three months of follow-up, they typically used PCS 
diagnosis (which can present in a variety of ways) as their benchmark outcome. However, since 
we are examining two specific manifestations of PCS (sleep disturbance and affective 
symptoms), we opted to include six months of follow-up.  
 
Participant Inclusion and Exclusion Criteria 
We will define “recent concussion” as any patient who is suspected of having suffered a 
concussion due to presence of concerning symptoms. This clinical suspicion may be based on the 
professional impression of a certified athletic trainer, team physician, or the patient's primary 
care physician. This professional impression should be based at least in part on thorough 
physical, neurological, and mental status examinations. Inclusion and exclusion criteria were 
adapted from operational criteria described in a 2014 World Health Organization (WHO) task 
force report on prognosis after mTBI as well as the 2013 Zurich consensus statement on 
concussion in sport [57, 58]. 
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Patients will be included if their symptoms stem from an acute injury that involved 
mechanical energy applied to their head, face, neck, or any other part of the body where the 
impulsive force may have been transmitted to the head. They must have a Glasgow Coma Scale 
(GCS) score of 13 to 15 (either immediately post-injury or upon later presentation for treatment), 
as well as at least one of the following: confusion, loss of consciousness (LOC) for at most 30 
minutes, amnesia for at most 24 hours, neurologic abnormalities not requiring surgery (e.g. focal 
lesions apparent on exam, seizure), or onset of general functional impairment within minutes to 
hours of the injury.  
Patients will be excluded if there is evidence of illicit drug use, there are associated 
injuries that may limit patient's ability to participate in objective measurements for purposes of 
the study (e.g. fractures or sprains), there is/was evidence of structural or physiological 
abnormality via neuroimaging, the patient is currently hospitalized, the patient has a major 
untreated medical or psychiatric comorbidity (e.g. epilepsy or major depression), the patient or 
their guardian (if applicable) are unable to complete the surveys administered as part of the study 
(e.g. due to visual, reading, or language comprehension difficulties), or the patient is already 
receiving medical treatment (beyond physical and cognitive rest) for post-concussion symptoms. 
Because the goal of this study is to observe subjects’ symptom progression at universal time 
points out to six months post-injury, patients whose concussion was more than two months prior 
to their initial PCC visit will be excluded. At the time of initial presentation to PCC, if a patient 
was recently started on a new prescription psychoactive medication, then initial evaluation via 
objective measures will be postponed until the patient returns to baseline (if it is a short course of 
prescription medication) or until a new baseline is established. No subjects will be excluded due 
to race, gender, ethnicity, or pregnancy status. 
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Study Measurements 
1. Patient Interview: 
The investigator will note the time elapsed since the patient's concussion event, as well as 
his or her basic demographics (including age, sex, and ethnicity) and insurance status (e.g. 
Private, Medicaid, None, or Other). History-taking will begin with a review of the patient's 
current cognitive function and how this has changed over time since their concussion event, 
including attention, concentration, memory, processing speed, reaction time, and whether or how 
often the patient feels like they are "in a fog." Other aspects of the patient's concussion event will 
also be reviewed, including the sport or activity involved, whether the patient was helmeted, 
whether the patient lost consciousness, medical attention they received, standardized post-
concussion assessments that were performed, and whether baseline results for these post-
concussion assessments are available. Further, the investigator will review whether any pain 
medications were prescribed or have been used, and (if the patient initially presents to the PCC 
more than one month after concussion) whether any new symptoms developed more than two 
weeks after the initial concussion event. 
Physical symptoms reviewed will include sensitivity to environmental stimuli (e.g. light 
or sound), headache symptoms (including laterality, severity, timing, and aggravating/attenuating 
factors), other new sources of recurrent pain or discomfort (particularly in the head and neck 
region), nausea, vomiting, vision changes, uneven gait, seizures, as well as any episodes of 
dizziness and/or syncope. Sleep will also be quantitatively and qualitatively reviewed, including 
number of hours of sleep per night, typical bed and awake times, sleep latency, snoring, and 
frequency of nighttime awakenings. Behavioral changes including irritability, depression, 
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anxiety, and problems with functioning or succeeding at work or school will be discussed. 
Finally, for all positive findings during this portion of the interview, it will be important to 
discuss how that symptom has changed over time, as well as comparing whether the patient also 
experienced that symptom prior to the concussion. 
Next, the investigator will review the patient's past medical history, with particular 
attention given to historical findings that may be associated with an increased risk of developing 
PCS. The investigator will start by discussing any concussions that the patient has experienced 
prior to the most recent one, including timeline, general clinical course, and the associated 
activity or sport. The investigator will also ask about the patient's sport-playing history and 
whether the patient has been in any motor vehicle collisions (MVC), as there is a chance that 
patients may have sustained concussions that they do not know about during sports or in MVCs.  
As far as neurological and psychiatric history, the investigator will inquire about any 
history of migraines or other recurrent headaches, including type of headache, associated 
symptoms, and typical severity. He or she will also ask whether the patient has had any previous 
diagnoses of affective, psychotic, or personality disorders. We will review any allergies that the 
patient has, as well as any medications taken regularly, including prescriptions, over-the-counter 
(OTC) medications, herbal supplements, recreational drugs, and drugs that were prescribed to 
someone other than the patient. Finally, the investigator will review the patient's history of 
tobacco use, alcohol consumption, previous hospitalizations, and surgical operations or other 
major procedures. 
As far as family history, the investigator will specifically inquire whether anyone in the 
patient’s family has a history of psychiatric disorders, including affective, psychotic, and 
personality disorders, Attention Deficit Hyperactivity Disorder (ADHD), somatization factitious 
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disorders, migraines or other recurrent headaches, and any concussions or other head injuries 
sustained by other members of the patient's family. For social history, the investigator will 
ascertain pre- and post-morbid work or academic difficulties experienced by the patient, as well 
as functional difficulties (e.g. attention, whether they complete chores, etc.) and the patient's 
exercise habits before and after their concussion. 
 
2. Physical Exam: 
All physical examinations will be performed by the investigator. After measuring vital 
signs (including height, weight, blood pressure, pulse rate, and respiratory rate), general 
inspection will include assessment of mood, appearance, level of cooperation with interview and 
physical exam, and whether the patient is in acute distress or exhibits increased work of 
breathing. Psychiatric exam will assess affect, thought process linearity, and orientation to 
person, place, time, and situation. HEENT (head, eye, ear, nose, throat) exam will include 
inspection for any head lesions and assessment of eye convergence, accommodation, tracking, 
and saccades. The investigator will also perform Vestibular-Ocular Motor Screening (VOMS). 
On skin, musculoskeletal (MSK), and extremity exam, the investigator will inspect for lumps, 
lesions over the cervical spine, cervical spine tenderness, cyanosis, clubbing, and edema. On 
neurologic exam, the investigator will assess strength in the upper extremities on the standard 
scale of 1 to 5 out of 5, reflexes, cranial nerves II through XII, and perform a Romberg test. 
 
3. Buffalo Concussion Treadmill Test (BCTT) [59]: 
Disruptions of cerebral autoregulation and consequent blood flow are common 
physiological sequelae of concussion. While exercise is thought to enhance brain neuroplasticity 
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and promote healing, many mTBI patients become somewhat deconditioned due to the 
prescribed period of physical and cognitive rest. This, together with the cerebral autoregulation 
disruptions, is thought to contribute to exercise intolerance in this population (due to 
exacerbation of PCS symptoms). The BCTT has proven to be a safe, reliable method of 
distinguishing concussion from differential diagnoses, determining the severity of concussion, 
and quantifying the exercise capacity of mTBI patients.  
To complete the BCTT, a patient starts by walking at a rate of 3.0 miles per hour (mph) 
and 0% incline. This incline increased by 1% after two minutes, and then by an additional 1% 
each minute thereafter without changing the speed. Rating of Perceived Exertion (RPE) and heart 
rate (HR) are measured every two minutes, and an assessment for exacerbation of post-
concussion symptoms is done every minute. The test is stopped when patient reaches RPE of 19 
or 20, when symptoms become exacerbated, or when HR reaches 140 beats per minute (bpm). If 
the treadmill's maximum incline is reached, then speed may be increased 1 mph every two 
minutes until stopping criteria are reached. 
 
4. Sensory Organization Test (SOT) [60]:  
This posturography assessment will be measured using the Smart Balance System and 
will be used as further assessment of postural stability. The device has two force plates that 
combine to form a platform base. Force sensors under this platform measure vertical and 
horizontal shear forces exerted by the patient's feet, which are used to estimate vertical reaction 
forces produced from the body's center of gravity moving around a fixed base of support, and the 
entire device is enclosed by a movable visual surround. During SOT measurements, the force 
plate, visual surround, or both can be "sway referenced," and move in accordance with the 
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subject's anteroposterior (AP) sway. The various permutations of sway referencing that are 
possible with SOT allows isolation of which afferent sensory modalities of the postural control 
system are dysfunctional following concussion, if any. Three different visual conditions (eyes 
open, eyes closed, sway referenced) are tested for each of two different surface conditions (fixed, 
sway referenced), for a total of eighteen trials of twenty seconds each.  
The device then computes a composite score of the patient's overall balance performance, 
indexed to the patient's height, weight, gender, and age. A higher composite score signifies better 
balance. The composite is computed based on the average score for condition #1 (eyes open, 
fixed platform), the average score for condition #2 (eyes closed, fixed platform), and the twelve 
equilibrium scores from each trial of the other four conditions. The equilibrium score from a 
given trial represents a non-dimensional percentage that compares the subject's peak amplitude 
of anterior/posterior sway to the theoretical anterior/posterior limit of stability. 
 
5. CNS Vital Signs (CNSVS) [61]: 
CNSVS is a computerized neurocognitive test that can administer a battery of well-
known neuropsychological tests without requiring a psychologist to be present. It has been 
shown to have good test-retest reliability and discriminant validity for a number of conditions, 
including post-concussion syndrome. However, it is only validated as a screening test; it is not 
meant for use in making a diagnosis. For this study, the neuropsychological function of all 
subjects will be assessed via CNSVS. Specifically, we will use the Verbal and Visual Memory, 
Finger Tapping, Symbol Digit Coding, Stroop, Shifting Attention, Continuous Performance, and 
Non-Verbal Reasoning testing modalities within this instrument. 
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6. Patient Reported Outcomes Measurement Information System (PROMIS) [62]: 
PROMIS is a toolbox of self-report quality of life survey instruments developed by the 
National Institutes of Health (NIH). They have three main advantages for this study: (1) 
PROMIS instruments are domain-specific (e.g. pain, cognitive function, social isolation) rather 
than disease-specific; (2) the instruments’ scoring was calibrated through trials with a large, 
diverse population, facilitating the identification of significant disruptions in well-being in 
concussed individuals; and (3) they are available in computer adaptive test (CAT) formats, which 
yields highly reliable approximations of results from the full item banks but can be completed in 
as little as one to two minutes per instrument. This study will utilize four of the PROMIS 
instruments: Anxiety, Depression, Fatigue, and Sleep. All four of these assessments were 
developed and validated using large, general population samples. Results for all PROMIS 
instruments are represented on a transformed scale (T-scale) with a mean score of 50 and a 
standard deviation of 10 [63].  
These four self-report instruments will be administered to subjects via Research 
Electronic Data Capture (REDCap), a free, web-based, electronic data capture tool for research 
studies that can also be used to conduct surveys. REDCap is a secure website that increases the 
ease of survey completion for subjects, and it includes the CAT formats of PROMIS instruments 
[64]. This will allow us to track multiple domains of each subject’s well-being with less risk of 
subject fatigue and consequent non-completion of surveys due to high testing burden. 
 
7. ICD-10 Major Depression Inventory (MDI) [65]: 
The symptomatology of PCS can overlap significantly with certain presentations of major 
depression. As such, it will be important to delineate whether study subjects meet the diagnostic 
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criteria for Major Depression Disorder (MDD), as this may impact treatment. Like the PROMIS 
tools, the ICD-10 MDI is relatively brief (12 questions) and is available for web-based 
administration free-of-charge via REDCap. Unlike other measures such as the PROMIS 
Depression tool or the Beck's Depression Inventory, the ICD-10 MDI is available to produce an 
ICD-10 diagnosis of MDD as well as track the severity of depressive symptoms over time.  
 
8. Pittsburgh Sleep Quality Index (PSQI) [66]: 
PSQI is a 19-item self-report that asks the subject to inventory their sleep over the prior 
month. These 19 items together generate scores for seven components: subjective sleep quality, 
sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping 
medication, and daytime dysfunction. This instrument was “designed to identify good and poor 
sleepers” as well as “groups that differ in the quality of their sleep,” and a threshold global score 
of 5 or greater suggests some degree of sleep impairment [66]. Mahmood and colleagues found 
an average PSQI score of 8.5 in a group of mTBI patients, which was about three points higher 
than that of the moderate or severe TBI groups in the same study [67]. Although the PSQI is 
somewhat vulnerable to recall bias given its self-report nature, it has several advantages in that it 
yields both qualitative and quantitative information about subjects’ sleep habits, and its 
components can be used to generate a diagnosis of insomnia. 
 
9. Munich Chronotype Questionnaire (MCTQ and MCTQ-Shift) [68, 69]: 
The MCTQ assesses individual chronotype on the basis of self-reported sleep- and wake-
time habits and preferences. Habits for work days versus free days are assessed separately in the 
questionnaire, which may prove to be a helpful feature once subjects begin to re-assimilate back 
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into their normal work and/or school schedules. Based on the subject's responses, the tool can be 
scored to determine whether the individual's degree of "morningness" (i.e. whether they prefer to 
go to bed and wake up early) versus "eveningness" (i.e. prefer to go to bed late and wake up late 
the next morning). These results can then be used in accordance with other measurements such 
as cognitive performance or daytime sleepiness. The MCTQ had been completed by over 55,000 
people as of 2007, and has been validated in concordance with sleeps logs and actimetry, and is 
correlated with biochemical rhythms such as melatonin and cortisol [70]. The MCTQ Shift is a 
related questionnaire that is specifically designed for shift workers, which we will use in subjects 
where this is applicable [69]. 
 
10. Post-Concussion Symptom Scale (PCSS) [71]: 
The PCSS is a 22-item instrument widely used to evaluate post-concussion symptoms. 
Subjects are asked to rate the severity of 22 different post-concussion symptoms on a 7-point 
Likert scale. While many of the symptoms covered by the PCSS may also be experienced by 
healthy patients, in the setting of concussion the PCSS is able to differentiate PCS patients on 
basis of affected domains (e.g. cognitive-fatigue-migraine, somatic, affective, sleep). There is 
evidence that the PCSS demonstrates good test-retest reliability and can also reliably detect 
changes in symptoms for a given patient. It is important to note that this inventory cannot be 
used to make any diagnoses other than PCS; it is simply used to document a patient’s self-
reported post-concussion symptoms. 
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Study protocol and procedures 
This is a prospective cohort study that will track the presence of risk factors and Post-
Concussion Syndrome (PCS) symptoms in a population of patients recovering from recent mild 
traumatic brain injury (mTBI). The study will be based at our Post-Concussion Clinic (PCC) 
located on the campus of a large research university, to which patients with recent concussion are 
referred from all over Eastern and Piedmont areas of North Carolina. If a patient who is referred 
to the PCC consents to participation in the study, then their initial evaluation will include 
detailed medical history, thorough physical exam, Sensory Organization Test (SOT), and CNS 
Vital Signs (CNSVS). This evaluation will help us identify the presence of pre- and post-morbid 
risk factors of PCS faced by the patient, characterize the mechanism of injury as well as 
neurological and functional deficits present at this initial PCC visit, and establish baseline data 
for each of these measurements for comparison in case the patient should need to return to the 
PCC for follow-up of a protracted case of PCS.  
The data from this initial visit will be collected in REDCap; a free, secure, web-based 
electronic data collection and management platform hosted by the university [72]. Our REDCap 
intake form is shown in Appendix #5, and our physical exam and clinical findings form is shown 
in Appendix #6. Although the history, physical exam, and treatment planning will need to be 
completed by the investigator (who is a physician) for purposes of insurance billing, there are 
otherwise no procedures that require specialized training. 
If a subject’s post-concussion symptoms do not improve within a reasonable amount of 
time, then subjects may need to follow-up in PCC, although this will not be necessary for 
completion of the study. Regardless of follow-up at the PCC or lack thereof, all subjects will 
receive notifications to respond to a series of surveys at six universal time intervals relative to the 
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date of their concussion: 1 month, 2 months, 3 months, 4 months, 5 months, and 6 months. At 
each of these time points, subjects will complete four PROMIS CAT measures (Anxiety, 
Depression, Fatigue, Sleep Impairment) as well as the ICD-10 MDI, Pittsburgh Sleep Quality 
Index (PSQI), and Munich Chronotype Questionnaire (MCTQ). Surveys will be administered via 
REDCap. Subjects will be contacted via email by default to complete follow-up surveys. If a 
given subject is non-respondent via email and has not completed a batch of surveys within 1 
week of the planned time point, a phone call will be placed to the subject to ascertain whether 
they wish to continue in the study. Surveys will not be administered over the phone to avoid 
interviewer bias. As of now, we have not planned a specific duration of this study. It will 
continue as long as it yields results of value.  
  
Benefits to subjects and/or society 
This study will benefit society by providing a longitudinal picture of the interactions 
between psychiatric (mainly affective) symptoms, sleep impairment, and functional deficits in 
the natural history and clinical course of PCS. This increased understanding could, in 
conjunction with future research work, lead to better prediction and treatment of PCS, thereby 
substantively decreasing the overall morbidity associated with concussion. Every patient who 
presents to Post-Concussion Clinic will receive all clinically-indicated evaluation, testing, and 
treatment, whether or not they elect to enroll as subjects in the study. Therefore, there is no 
potential for direct benefit to individual subjects in the study. 
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Risks, and risk minimization 
Tests of postural control and neurocognitive ability may elicit embarrassment as well as 
some degree of emotional distress, particularly if a subject is worried about doing poorly or if 
they are a relatively high-functioning individual at baseline. To mitigate this risk, both postural 
control and neurocognitive testing will be performed behind a closed door, with only the subject 
and the investigator or a research assistant present in the room. Reassurance will be provided to 
each subject that only the researchers will see their results, and that these tests are not meant to 
pass any sort of judgement, but instead provide one part of an overall clinical picture that is 
needed in order to devise a targeted treatment plan. 
Another component of the study that may provoke emotional distress is the historical 
interview, which will include questions about illicit drug use, personal and family psychiatric 
history, history of abuse, and other potentially sensitive issues. Similar to the above, the 
historical interview will take place in a private room with the door closed, where the only people 
present are the subject, an investigator and/or research assistant, and anyone who the subject 
wishes to have with them. Further, subjects will be informed at the start of the visit that they may 
decline to respond to any questions that they do not wish to answer. Subjects will be asked about 
illicit substance use as a standard part of the historical interview. This information will be kept 
confidential. Documentation of this information will only be kept on the secure, web-based, 
password-protected electronic data capture system that will be used for this study. Only the 
investigators will have access to this data. 
It is considered likely (approximate incidence of 10 to 25%) that the SOT and/or exercise 
testing will elicit nausea, headache, or other post-concussion symptoms that the subject has been 
experiencing. Exercise testing is specifically designed to test the subject’s limits of exertion, but 
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testing will be stopped as soon as a subject expresses discomfort. There are also many PCC 
patients who achieve a high heart rate on exercise testing without experiencing symptoms. 
However, if the need should arise while working with a subject, researchers will help subjects 
seek medical or psychological care (billed to the subject's own insurance).  
Further information concerning expected typical subject contact and duration of 
involvement in the study, as well as planned precautions in regard to subject confidentiality and 
privacy are described in Appendix #7. Data and safety monitoring plans are described in 
Appendix #8.  
 
Plans for data analysis 
This paper proposes an exploratory, prospective cohort study with a primary aim of 
describing the natural history of PCS. In particular, it will focus on two important manifestations 
of PCS (namely, sleep disturbance and affective symptoms). The study will involve evaluating 
whether certain historical factors and clinical findings at the pre-injury and/or acute post-injury 
stages are statistically significant predictors of an increased burden of sleep disturbance and 
affective symptoms over the first six months of the post-concussion period. Due to uncertainty 
over what these relationships will look like, we will complete a pilot study for the predictor-
outcome pairs where both are continuous measurements. Afterward, we will graph each subjects' 
response curves for these continuous predictor-outcome pairs of interest (detailed above in Study 
Aims) in order to choose an appropriate model to evaluate the statistical significance of our 
findings from a larger sample. Prior studies in this area of research (such as those covered in our 
systematic review) have typically used some combination of linear, logistic, or generalized linear 
mixed model regression analyses to achieve these ends. 
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For the relationships of interest with dichotomous predictor variables, we will use 
summary measures to describe our serial measurements, using the method outlined by Matthews 
and colleagues [73]. A list of predictor-outcome pairs that we will describe for this aspect of our 
planned data analyses can be found in Appendix #9. Briefly, after stratifying for a potential 
predictor (e.g. subjects with no prior history of concussion versus those with a history of multiple 
concussions), we will seek to describe the central tendency and within-subject variability of 
subjects' recovery trajectories (as judged by outcomes such as PROMIS Sleep survey scores), 
stratified by exposure group for that potential predictor. Response curves expected to have a 
peak or trough will be described by their maximum/minimum value and area under the curve 
(AUC). Response curves expected to show only growth or decline will be described by their rate 
of change. Data transformations may be applied (e.g. logarithmic) if deemed appropriate. All 
summary measures will include 95% confidence intervals. 
To be clear, this study seeks to explore and describe the predictor-outcome variable pairs 
of interest (as well as any additional predictors that may present themselves) in order to identify 
pairs that might be suitable for robust significance testing in a future iteration of the study. We 
currently have no data on the prevalence or severity of any given PCS symptoms within our 
clinic population, so any sample size calculation is a rough estimate at best. To ensure that we a 
sufficient number of subjects to make substantive observations, though, we calculated a 
conservative estimate using G*Power 3.1 [74].  
To estimate a reasonable effect size, we looked at previous data for PSQI global scores. 
Our literature search did not yield any longitudinal studies describing the variance and within-
subject correlation of PSQI in a population of mTBI patients over time. From our systematic 
review, though, we have PSQI global estimates of  6.35 (n = 689; 95% CI: 5.93, 6.77) [35], 6.72 
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± 4.00 (n = 77) [37] among mild TBI patients, as well as a separate finding by Mahmood and 
colleagues of 8.54 ± 5.87 (n = 24) on average [67]. In addition, the original PSQI validation 
study found an average global score of 11.09 ± 4.31 in depressed patients (n = 34) and 2.67 
±1.70 in healthy controls (n = 52) [66]. Therefore, it appeared reasonable to expect potential 
predictors of increased symptom burden to demonstrate at least a moderate effect size of 0.5 
(Cohen’s d) to warrant further evaluation in future iterations of this study. Using G*Power’s 2-
sample t-test calculator with alpha = 0.05, power = 0.8, and N2/N1 allocation ratio = 1 (since 
50% of mTBI patients complain of sleep disturbance [49]), we can see that a sample size of at 
least 128 subjects would allow detection of an effect size of 0.5 with 80% power. Demographic 
factors such as age, sex, and certain psychosocial factors (e.g. family income, insurance status) 
will be evaluated as potential confounding variables for each predictor-outcome pair.  
This simplified calculation using the 2-sample t-test provides a conservative of the 
sample size that will be required, since our study will include six follow-up measurements of 
PSQI and other survey instruments (rather than just one measurement), and the effect size is 
likely to be significantly greater than 0.5. Further, this calculated required sample size of at least 
128 is in line with similar studies in this area of research [29, 33, 34, 39]. We feel this sample 
size will be feasible for our subject recruitment method. Over the past nine months (October 
2015 to March 2016), the PCC has seen an average of about two new patients per week. If this 
rate of new patients continues, and if most PCC patients assent to participation (a reasonable 
assumption given the low risk of doing so), then we expect to meet this sample size requirement 
within 18 months of beginning the study. 
 
  
  
Palm 49 
Conclusions and Public Health Implications 
Concussion has been in the news a lot lately. Over the past few years it has been the 
subject of many newspaper articles, sports talk show segments, and even a Hollywood movie. 
The resultant increased public awareness has led to a number of actions in professional, college, 
and youth sports. These have included primary prevention strategies (e.g. rule changes, sports 
equipment improvements) and secondary prevention (e.g. mandatory removal if a concussion is 
suspected, return-to-play protocols). Although it still too early to rigorously assess these 
interventions, there is a consensus that they have led to improved recognition of concussion 
events, and should theoretically help prevent some of concussion’s most severe consequences 
(e.g. CTE and SIS). 
However, a significant portion of concussion’s public health burden stems from PCS, 
which is not as well understood and has not received as much public attention. The above 
systematic review found that PCS has been shown to last months or even years some patients. 
However, thus far there have been few studies examining the mechanisms of and interactions 
between specific, potentially treatable manifestations of PCS. 
Here, we have proposed a research design to help close this gap in scientific knowledge 
by tracking the burden of post-concussion sleep disturbance and affective symptoms in a 
prospective cohort study of patients with recent mTBI. The goal of this study will be mainly to 
identify and describe predictor-outcome that could be tested for statistical significance in a future 
iteration of the study. Traditionally, PCS has been conceptualized as a single entity, despite its 
wide variety of clinical presentations. Our proposed study is meant as a first step towards 
identifying targeted interventions for PCS, which would provide an additional secondary 
prevention strategy to reduce the public health burden of concussions.  
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Appendix #1: PECOTTSS study inclusion and exclusion criteria 
PECOTTSS Inclusion Exclusion 
P (Population) Adolescents, Adults Military, Veterans, Children less than 
12 years old 
E (Exposure) Concussion / Mild TBI Moderate/Severe TBI, Skull fracture, 
Blast injury 
C (Comparator) Historical factors and acute 
post-injury clinical findings 
Clinical trials of treatment 
interventions 
O (Outcomes) 
Sleep disturbance, Affective 
symptoms in the post-
concussion setting 
Serum biomarkers, imaging, survey 
outcomes that did not focus on sleep 
or affective symptoms 
T (Time of exposure) Greater than one month of 
follow-up measurements 
1 month or less of follow-up 
measurements 
T (Time over which 
literature will be 
searched) 
Published within the past 10 
years 
Publication prior to June 2006 
S (Setting) Any None 
S (Study Design) Observational studies (e.g. 
cohort, case-control) 
Clinical trials, Review articles will be 
hand searched for relevant citations 
Abbreviations: TBI = Traumatic Brain Injury 
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Appendix #2: Search strategy for PubMed and Cochrane Library databases 
Search # Query PubMed (# items) 
Cochrane 
(# items) 
1 Search post-concussion syndrome 901 51 
2 Search adult 6376694 393388 
3 Search adolescent 1756782 103394 
4 Search humans 159545585 550937 
5 Search (#2 or #3 or #4) 16241993 639278 
6 Search concussion 7829 214 
7 Search brain injuries 76396 1908 
8 Search (#6 or #7) 77739 2031 
9 Search depressive disorder 108015 12403 
10 Search mood disorders 120356 4177 
11 Search panic disorder 11133 2176 
12 Search risk factors 997953 53260 
13 Search sleep 158272 19633 
14 Search sleep initiation and maintenance disorders 10210 1599 
15 Search sleep wake disorders 70282 1531 
16 Search time factors 1366160 79746 
17 Search Athletic Injuries/complications 2170 30 
18 
Search (#9 or #10 or #11 or #12 or #13 or #14 or #15 or 
#16 or #17) 
2385333 139910 
19 Search (#1 and #5 and #8 and #18) 291 15 
20 Restricted #19 to studies published within last 10 years 222 12 
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Appendix #3: Results of literature search and screening process (PRISMA diagram) 
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(n = 17) 
Hand searches of reference lists: 17 
ClinicalTrials.gov: n/a 
Records after duplicates removed 
(n = 243) 
Records screened 
(n = 243) 
Records excluded 
(n = 159) 
Full-text articles assessed 
for eligibility  
(n = 84) 
( 
Full-text articles excluded, 
with reasons 
(n = 69) 
Studies included in 
qualitative synthesis 
(n = 15) 
Studies included in 
quantitative synthesis 
(e.g. meta-analysis) 
(n =   n/a) 
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Appendix #4: Summarized characteristics of studies included in the systematic review 
Authors 
(Year) 
Sample Study Design Measurements Key Findings Strengths Limitations 
Chaput, 
Giguère, 
Chauny, et al. 
(2009) [40] 
• Chart review of 443 
consecutive patients 
receiving diagnosis 
of mTBI 
• Majority male 
(62.8%) with mean 
age of 46.9 years 
Retrospective 
cohort study with 
follow-up at 10 
days and 6 weeks. 
• RPQ 
• Self-reported 
sleep complaints, 
classified into six 
categories 
• Subjects with sleep 
complaints at 10 days 
were 6.3 times more 
likely to express mood 
complaints at 6 weeks 
• Sleep disturbances 
affected 13.3% and 
33.5% of subjects at 10 
days and 6 weeks, 
respectively 
• Reasons for sleep 
disturbance evolved over 
time 
• Large sample size 
• Able to show 
evolution of sleep 
disturbance 
symptoms 
• Subjective report of 
specific sleep 
complaints 
• Did not examine 
confounding due to 
social/economic 
stressors or subjects' 
pre-morbid medical 
issues 
Dischinger, 
Ryb, Kufera, 
et al. (2009) 
[29] 
• 180 mTBI patients 
presenting to a level 
I trauma center 
within 3 days of 
head injury 
• About half were 
men, and most 
subjects had been in 
MVC. 
Prospective 
cohort study with 
follow-ups at 10 
days and 3 
months. 
• PHQ-2 
• Authors' 
concussion 
symptom 
checklist 
• Acute complaints of 
anxiety predicted 
presence of PCS at 3 
months, but acute-stage 
fatigue was not 
• Subjects with pre-injury 
depression were 3.56 
times more likely to 
experience PCS at 3 
months (univariate OR) 
Assessed predictiveness 
of individual, treatable 
symptoms (rather than 
categories of 
symptoms) for 
development of 
persistent PCS.  
• Non-validated post-
concussion symptom 
survey 
• 110 subjects followed 
up at 3 months (39% 
dropout) 
• Did not assess sleep 
disturbance symptoms 
• Did not explain 
sampling protocol 
• Referral bias (Level I 
trauma center) 
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Authors 
(Year) 
Sample Study Design Measurements Key Findings Strengths Limitations 
Eisenberg, 
Andrea, 
Meehan, et al. 
(2013) [30] 
• 280 mTBI patients 
with history of 
previous mTBI 
• Enrolled upon 
presentation to ED 
within 72 hours of 
head injury 
• 11 to 22 years of age 
Prospective 
cohort study with 
12 weeks of 
follow-up. 
RPQ • Multiple previous 
concussions or 
concussion with past year 
associated with persistent 
PCS symptoms 
• Pre-injury depression 
associated with increased 
time to recovery 
• Able to show that 
PCS-related effects 
of multiple 
concussions can be 
additive 
• Distinguished 
between timing and 
number of previous 
concussions 
• Increased sensitivity 
from using broad 
definition of 
concussion 
• 207 (74%) subjects 
completed the study 
• As a group, subjects 
lost to follow-up were 
significantly different 
in terms of 
demographics and 
past medical history 
• Referral bias (subjects 
recruited from ED) 
• Sample size too small 
too assess PCS 
predictiveness of 
many acute and pre-
injury medical issues 
• No control group 
Eisenberg, 
Meehan, and 
Mannix (2014) 
[31] 
• Same cohort as 
above 
• 280 mTBI patients 
with history of 
previous mTBI 
• Enrolled upon 
presentation to ED 
within 72 hours of 
head injury 
• 11 to 22 years of age 
Prospective 
cohort study with 
12 weeks of 
follow-up. 
RPQ • 21.6% developed sleep 
disturbance after initial 
evaluation 
• Sleep disturbance was 
among the most persistent 
PCS symptoms 
• Depression symptoms 
tended to resolve quickly 
• No difference in 
individual symptoms 
among subjects with 
recent or multiple 
previous concussions 
Prospective design 
allows description of 
symptom evolution 
over course of recovery 
in a pediatric 
population. 
• Did not examine 
interactions between 
symptoms 
• Did not assess effects 
of individual 
symptoms on work or 
school performance 
• Referral bias 
(recruited from ED) 
• No control group 
Greenberg, 
Wood, Spring, 
et al. (2015) 
[32] 
• 14 subjects 
• Enrolled within 96 
hours of 
presentation to ED 
Prospective 
cohort pilot study 
with follow-ups at 
1 month and 3 
months post-
injury. 
• Authors' battery 
of NSS 
maneuvers 
• RPQ 
• BDI-II 
• Acute-stage BDI-II 
scores did not 
significantly correlate 
with global RPQ scores at 
follow-up time points 
• On average, BDI-II 
scores declined at each 
follow-up time point 
• Strict inclusion and 
exclusion criteria 
• Small sample size 
• Not high-powered 
enough to detect 
associations between 
many of the measures 
used 
• Referral bias 
(recruited from ED) 
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Authors 
(Year) 
Sample Study Design Measurements Key Findings Strengths Limitations 
Hou, Moss-
Morris, 
Peveler, et al. 
(2011) [33] 
• 126 mTBI patients 
• Recruited within 2 
weeks of 
presentation to ED 
• 18 to 60 years of age 
Prospective 
cohort study with 
follow-ups at 3 
months and 6 
months post-
injury. 
• HADS 
• RPQ 
• HADS anxiety was a 
predictor for PCS at 3 
months and 6 months 
• HADS depression was a 
predictor for PCS at 3 
months and 6 months 
• Sleep disturbance was 
among the most common 
symptoms reported 
• Large sample size 
• Used a wide array 
of assessment tools 
and examined 
potential 
interactions between 
their results 
Assessments used are 
validated but not 
commonly used among 
similar studies. 
Kempf, 
Werth, Kaiser, 
et al. (2010) 
[34] 
• 51 TBI patients 
recruited 
consecutively from 
the ED 
• All subjects had no 
history of TBI 
• Median age of 40 
years 
Prospective 
cohort study with 
follow-ups at 6 
months and 3 
years post-injury. 
• ESS 
• FSS 
• Sleep Length per 
24 hours 
• Standardized 
interview via 
telephone 
• BDI 
• Daytime sleepiness and 
overall sleep-wake 
disturbances fell between 
6 months and 3 years 
post-TBI 
• Prevalence of fatigue, 
post-traumatic 
hypersomnia, and 
insomnia all increased 
among subjects 
• Depression and fatigue 
were significantly 
correlated 
• Long-term follow-
up 
• Small sample size 
• Vulnerable to 
interviewer bias 
• Did not use validated 
questionnaires for 
many symptom 
assessments 
Kostyun, 
Milewski, and 
Hafeez (2014) 
[41] 
• 545 adolescent 
athletes 
• 11 to 18 years of age 
• Included if they 
completed first 
neurocognitive test 
within 90 days of 
head injury 
Retrospective 
cohort study with 
up to three 
follow-ups at 
non-universal 
time points. 
• ImPACT 
• PCSS 
• Sleeping less than 7 hours 
and self-perception of 
sleep disturbance were 
both correlated with 
greater self-reported PCS 
symptom severity 
• Sleeping longer than 9 
hours correlated with 
poorer cognitive 
performance 
• Several months of 
follow-up for a 
subset of the 
patients 
• Larger sample size 
than many similar 
studies of 
concussion 
• Follow-ups not 
conducted at universal 
time points 
• Majority of subjects 
did not return for 
second or third 
follow-ups 
• Sleep quantity and 
quality measured via 
self-report 
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Authors 
(Year) 
Sample Study Design Measurements Key Findings Strengths Limitations 
Kraus, Hsu, 
Schaffer, et al. 
(2009) [35] 
• 689 mTBI patients 
and 1318 patients 
with non-head 
injuries 
• Recruited from ED 
Prospective 
cohort study with 
3 months of 
follow-up. 
• RPQ 
• PSQI 
• BSI-18 
• Increased sleep latency 
and daytime dysfunction 
were more common in 
mTBI group 
• Fatigue and sleep 
disturbance were most 
common symptoms 
reported in mTBI group 
• 38% lost to follow-
up 
• Large sample size 
• Control group 
included 
• Included confounding 
variables in statistical 
model on basis of 
Table 1 chi-squared 
calculations 
• Differential loss to 
follow-up between 
groups 
• Vulnerable to 
telephone interviewer 
bias 
Lagarde, 
Salmi, Holm, 
et al. (2014) 
[36] 
• 534 patients with 
head injury 
• 827 control patients 
with non-head 
injuries 
Prospective 
cohort study with 
3 months of 
follow-up. 
A symptom survey 
created for the study, 
which drew from 
DSM-IV, ICD-10, 
and RPQ. 
• mTBI (vs. non-head 
injury) was predictive of 
PTSD but not PCS at 3 
months post-injury 
• At three months post-
injury, prevalence of PCS 
in mTBI group varied 
from 21.2% to 53.4%, 
depending on definition 
used 
• Large sample size 
• Included a control 
group 
• Accounted for 
differing definitions 
of PCS 
• Considerable amount 
of missing data 
• Differential loss to 
follow-up by age of 
subjects 
Lundin, de 
Boussard, 
Edman, et al. 
(2006) [27] 
• 122 consecutive 
patients with mTBI 
recruited from ED 
• 35 controls recruited 
via magazine 
advertisement 
Prospective 
cohort study with 
follow-ups at 1, 7, 
and 14 days, and 
3 months post-
injury. 
RPQ • Principal component 
analysis included both 
sleep disturbance and 
depression in the 
"affective" category 
• Sleep disturbance was 
reported by 21% of 
subjects in both groups 
• Included a control 
group that was 
similar to 
observation group in 
terms of baseline 
characteristics 
• Shows the 
progression of PCS 
symptoms from 
acute to chronic, 
which could be used 
to infer causality 
• High non-
participation rate 
• Participating group 
may be biased 
towards patients with 
more severe injuries 
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Authors 
(Year) 
Sample Study Design Measurements Key Findings Strengths Limitations 
Morgan, 
Zuckerman, 
Lee, et al. 
(2015) [42] 
40 cases of PCS with 80 
controls (matched on 
age and sex) drawn 
from concussion clinic 
database. 
Retrospective 
matched case-
control study with 
3 months of 
follow-up 
• Cases had 
documented PCS 
symptoms for at 
least 3 months 
• Controls had 
resolution of 
PCS symptoms 
within 3 weeks 
of injury 
Subjects more likely to 
develop PCS if they had 
delayed-onset of symptoms 
or a personal or family 
history of psychiatric 
diagnoses. 
Contributes new data on 
the risk factors of 
prolonged PCS in 
pediatric patients. 
• Utilized records from 
a number of different 
providers (trainers, 
doctors, etc.) that may 
have applied varying 
criteria in making a 
clinical diagnosis 
• Matched based on 
sex, so sex could not 
be examined as a risk 
factor 
Schmidt, Li, 
Hanten, et al. 
(2015) [37] 
• 71 patients with 
recent mTBI 
• 71 patients with 
recent orthopedic 
injury 
• Both of the above 
recruited 
consecutively in ED 
• 43 controls with no 
recent injury 
Prospective 
matched cohort 
study with 
follow-ups at 1 
month and 3 
months post-
injury. 
PSQI • Fatigue and PTSD 
prevalence differed at all 
three time points 
• Overall, mTBI group had 
greater sleep disturbance 
and PTSD prevalence at 
all three time points 
• Sleep disturbance 
differential not seen in 
younger age groups 
• Able to detect 
delayed onset of 
some symptoms 
• Shows evolution of 
sleep impairment 
symptoms over time 
• Stratified analysis 
able to differentiate 
symptoms based on 
age group 
  
• Did not directly 
compare PSQI results 
to PTSD incidence 
• Did not attempt to 
assess pre-morbid 
sleep 
• Did not exclude based 
on medications (e.g. 
substances that may 
affect the brain) 
Tham, 
Palermo, 
Vavilala, et al. 
(2012) 
• 729 patients with 
TBI 
• 197 controls with 
orthopedic injury 
• All subjects 2 to 17 
years of age 
Prospective 
cohort study with 
control group 
(matched for age 
and sex) with 
follow-ups at 3, 
12, and 24 
months. 
• PedsQL 
• PSC-17 
• ABAS-II 
• mTBI associated with 
greater sleep disturbance 
• Female gender, 
psychosocial problems, 
and frequent pain were 
significant risk factors for 
sleep disturbance 
• Sleep disturbance 
predicted poor self-care 
Large sample of 
patients suffering from 
recent TBI, with well-
matched control cohort. 
• First follow-up was 
not until 3 months 
post-injury 
• Did not include 
healthy control 
Whittaker, 
Kemp, and 
House (2007) 
• 73 patients who 
presented to ED 
with mTBI 
• Mean age was 41 
years 
Prospective 
cohort study with 
follow-up at 3 
months. 
• RPQ 
• IPQ-R 
• IES 
• HADS 
Subjects who believed the 
duration of PCS symptoms 
would be closer to that of a 
chronic disease than a viral 
illness were more likely to 
suffer prolonged PCS 
symptoms, including sleep 
disturbance. 
Operationalizes the 
hypothesized 
psychosocial 
contribution to PCS 
development in order to 
examine how strongly 
these beliefs predict 
PCS. 
• Vulnerable to 
interviewer bias 
(telephone) 
• Non-participation rate 
of about 90% 
• Non-participants not 
compared as a group 
to subjects 
Appendix #4 Abbreviations: ABAS-II = Adaptive Behavior Assessment System-II; BDI-II = Beck Depression Inventory; BESS = Balanced Error Scoring System; BSI-18 = 
Brief Symptom Inventory-18; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders-IV; ED = emergency department; ESS = Epworth Sleepiness Scale; FSS = Fatigue 
Severity Scale; HADS = Hospital Anxiety and Depression Scale; ICD-10 = International Statistical Classification of Diseases and Related Health Problems; IES = Impact of Event 
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Scale; ImPACT = Immediate Post-Concussion Assessment and Cognition Testing; IPQ-R = Illness Perception Questionnaire-Revised; mTBI = mild traumatic brain injury; MVC = 
motor vehicle collision; NSS = Neurological Soft Signs; PCS = Post-Concussion Syndrome; PCSS = Post-Concussion Symptom Scale; PedsQL = Pediatrics Quality of Life 
Inventory; PHQ-2 = Personal Health Questionnaire - 2; PSC-17 = Pediatric Symptom Checklist-17; PSQI = Pittsburgh Sleep Quality Index; PTSD = Post-Traumatic Stress 
Disorder; RPQ = Rivermead Post-Concussion Questionnaire 
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Appendix #5: Preview of new patient intake form (for use in REDCap) 
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Appendix #6: Preview of initial clinic visit form (for use in REDCap) 
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Appendix #7: Subject Contact, Duration, Privacy, and Confidentiality 
Number of Subject Contacts: At least five contacts (subject's initial visit to PCC plus four 
batches of follow-up surveys sent via email). Subjects are welcome to schedule additional 
follow-up visits at the PCC as clinically indicated, but this is not required for participation. 
  
Duration of Subject Participation in Study: 1.5 hours for initial clinical visit to PCC, including 
history, physical exam, and standardized post-concussion tests. Follow-up batches of survey 
instruments will be emailed to subjects at pre-defined universal time points (at 1, 2, 3, 4, 5, and 6 
months post-injury), and on average these should require no more than 60 minutes to complete, 
at each follow-up time point. Therefore, this study will involve at most a 7.5-hour time 
commitment (1.5 hours for initial PCC visit plus 6 x 60 minutes per batch of follow-up survey 
instruments), providing that no follow-up visits to PCC are required. Of note, this estimated time 
commitment does not include travel time to and from PCC. While travel time is relatively brief 
for many PCC patients, in the past referrals have come from as far away as Wilmington (about 3 
hours' one-way drive from Chapel Hill).  
  
Participant Privacy: Each subject's initial evaluation will be conducted entirely at the sports 
medicine and training facility on the campus of a large research university. Physical copies of 
identifiable information generated from these encounters will be kept in a locked filing cabinet at 
the PCC. No testing results, and no identifiable information on computer screens or on paper will 
be visible to anyone other than the subject, their parent or guardian (if subject is a minor), and 
the co-investigator(s) conducting the evaluation. When working on the computer to provide 
demographic information or to complete CNSVS neuropsychological test battery, the door to the 
computer lab will be closed, or if need be, a physical divider will be placed between subjects 
working on adjacent computers. Patients will not receive any stipends, reimbursements, or 
otherwise tangible incentives for participation. They will bear no cost for participation beyond 
the cost of the clinic visit itself. 
  
Subjects' responses to follow-up surveys administered via REDCap will similarly be neither 
visible nor accessible to anyone not on the immediate research team for this study. Although we 
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cannot guarantee subjects' privacy when completing follow-up surveys off-site, subjects will be 
counseled to position themselves and their computer in such a way that their screen is not visible 
to others while they are responding to the surveys, in order to maintain their privacy. 
  
Participant Confidentiality: All potential study subjects will be informed of their rights via 
counseling and an informed consent form. Potential subjects will be advised in person and via 
the informed consent form that they have the right not to participate in the study, and that a 
decision not to participate will affect neither their status as a patient at the PCC nor eventual 
decisions to clear the patient for return to activity. Data will only be seen or accessed by 
members of the study's research team, and will be kept locked in a file cabinet within the 
Matthew Gfeller Sport-Related Traumatic Brain Injury Center on the UNC-Chapel Hill campus. 
The data will be password-protected, and the computers and servers used to store the data will 
also be stored in securely-locked rooms. Personal names and email addresses will not be stored 
on the electronic data files. Subjects who are longitudinally followed will be assigned a unique 
master identification number that will be used to link the multiple data records on that patient. 
  
As part of the study, we will be evaluating the effects of past and present factors upon the natural 
history and clinical course of PCS in a longitudinal manner among patients who have recently 
suffered TBI. As such, we will need to assess any historical factors that may affect subjects' 
neurological function and mental status, as these factors may also have a bearing upon the 
incidence and persistence of PCS. The factors to be assessed are personal and family history of 
psychiatric conditions (including affective, psychotic, and personality disorders) as well as 
corresponding treatments for those conditions, HIV status, and past or present recreational drug 
use. We will also collect information on social factors that may include a history of physical 
abuse, difficult family environment, or socioeconomic disadvantage. 
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Appendix #8: Data and Safety Monitoring 
Data will be stored within REDCap, a cloud-based data capture application that uses 
secure web authentication, data logging, and Secure Sockets Layer (SSL) encryption. Only 
members of the research team will have password-protected access to this data. Data will not be 
shared with anyone outside the immediate research team. Following completion of the study, all 
physical materials with identifying information will be shredded to the extent that no information 
can be obtained from the shredded documents. 
  Data will be monitored for poor patient outcomes, adverse effects from testing, and other 
indications of possible safety concerns by a co-investigator at least once annually. If safety 
concerns should arise, the co-investigator will report the concern to the primary investigator as 
well as the IRB. There will be no specific criteria used for withdrawing individual subjects from 
the study, provided that they meet the inclusion and exclusion criteria and are willing to continue 
participation. As we are not testing any novel interventions, we have not defined criteria for 
halting the entire study due to safety concerns, and this study will not involve a data and safety 
monitoring board or committee.   
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Appendix #9: Predictor-Outcome pairs of interest 
Aim Predictor(s) Predictor Data Type Outcome(s) 
Outcome 
Data Type 
1(a) 
Pre-injury sleep 
impairment (based on 
history-taking) 
Dichotomous PSQI global score, PROMIS Sleep Continuous 
1(b) 
Pre-injury personal or 
family history of 
psychiatric diagnoses 
(based on history-
taking) 
Dichotomous PSQI global score, PROMIS Sleep Continuous 
1(c) 
History positive for 
multiple concussions 
(based on history-
taking) 
Dichotomous 
PSQI global score, PROMIS 
Sleep, MDI-10, PROMIS 
Depression, PROMIS 
Anxiety 
Continuous 
2 PSQI global score at 1-month follow-up Continuous 
PSQI global score (full six 
months of follow-up), 
PROMIS Sleep, MDI-10, 
PROMIS Depression, 
PROMIS Anxiety 
Continuous 
3 
PSQI global score, 
PROMIS Sleep, MDI-
10, PROMIS 
Depression, PROMIS 
Anxiety 
Continuous PCSS global score Continuous 
4 MCTQ at time of clinic visit Categorical 
PSQI global score, PROMIS 
Sleep, MDI-10, PROMIS 
Depression, PROMIS 
Anxiety, PCSS global score 
Continuous 
 
